Home » Topics » Disease categories and therapies » Neurology/psychiatric

Neurology/psychiatric
RSS

BioChem Pharma synthesizes opioid analgesics/NMDA antagonists

March 19, 1997

Cephalon discloses cysteine/serine protease inhibitors

March 19, 1997

Avonex approved by European Commission

March 18, 1997

Lanepitant not effective in migraine

March 18, 1997

Pharmacodynamics and safety of the dopamine agonist CI-1007

March 18, 1997

Topical anesthesia with liposome-encapsulated tetracaine

March 18, 1997

Neuroprotective, analgesic and antitussive agents from Toray

March 18, 1997

Aricept cleared for marketing in U.K.

March 17, 1997

New therapy for essential tremor recommended for approval

March 17, 1997

SIB-1508Y associated with improvement in cognitive deficits in Parkinson's model

March 17, 1997

Popular Stories

Today's news in brief
BioWorld
SCAN is core circuit affected in Parkinson’s disease
BioWorld Science
Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...
TL1A is overexpressed in hidradenitis suppurativa
BioWorld Science
Despite the availability of advanced therapeutic options, about 40%-50% of patients with hidradenitis suppurativa do not achieve significant improvement in...
IL-22 and TL1A, a robust couple for diagnosing hidradenitis suppurativa
BioWorld Science
Hidradenitis suppurativa (HS) is a chronic inflammatory skin disease with strong association with psoriasis and inflammatory bowel disease (IBD). While some...
Astellas’ ASP-2246 shows promise in stroke management
BioWorld Science
Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...